Hims & Hers Health, Inc. (HIMS)
NYSE: HIMS · Real-Time Price · USD
28.27
+2.62 (10.21%)
At close: May 8, 2026, 4:00 PM EDT
29.09
+0.82 (2.90%)
After-hours: May 8, 2026, 7:59 PM EDT
Hims & Hers Health Market Cap
Hims & Hers Health has a market cap or net worth of $6.53 billion as of May 8, 2026. Its market cap has increased by 4.49% in one year.
Market Cap
6.53B
Enterprise Value
7.08B
1-Year Change
4.49%
Ranking
Category
Stock Price
$28.27
Market Cap Chart
Since September 13, 2019, Hims & Hers Health's market cap has increased from $246.53M to $6.53B, an increase of 2,549.72%. That is a compound annual growth rate of 63.63%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 6.53B | -11.63% |
| Dec 31, 2025 | 7.39B | 39.92% |
| Dec 31, 2024 | 5.28B | 180.00% |
| Dec 29, 2023 | 1.89B | 41.69% |
| Dec 30, 2022 | 1.33B | -0.30% |
| Dec 31, 2021 | 1.34B | 263.65% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Sep 13, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neurocrine Biosciences | 15.31B |
| Regencell Bioscience Holdings | 14.48B |
| Elanco Animal Health | 11.81B |
| Dr. Reddy's Laboratories | 11.40B |
| Lantheus Holdings | 6.05B |
| Alkermes | 5.83B |
| Kiniksa Pharmaceuticals International, | 4.51B |
| Amneal Pharmaceuticals | 4.21B |